Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases

Following the involvement of CHCHD10 in FrontoTemporal-Dementia-Amyotrophic Lateral Sclerosis (FTD-ALS) clinical spectrum, a founder mutation (p.Gly66Val) in the same gene was identified in Finnish families with late-onset spinal motor neuronopathy (SMAJ). SMAJ is a slowly progressive form of spinal...

Full description

Bibliographic Details
Main Authors: Emmanuelle C. Genin, Sylvie Bannwarth, Françoise Lespinasse, Bernardo Ortega-Vila, Konstantina Fragaki, Kie Itoh, Elodie Villa, Sandra Lacas-Gervais, Manu Jokela, Mari Auranen, Emil Ylikallio, Alessandra Mauri-Crouzet, Henna Tyynismaa, Anna Vihola, Gaelle Augé, Charlotte Cochaud, Hiromi Sesaki, Jean-Ehrland Ricci, Bjarne Udd, Cristofol Vives-Bauza, Véronique Paquis-Flucklinger
Format: Article
Language:English
Published: Elsevier 2018-11-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996118303486
id doaj-4dd012f21baf4cd2b4f522f52e36c6f3
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Emmanuelle C. Genin
Sylvie Bannwarth
Françoise Lespinasse
Bernardo Ortega-Vila
Konstantina Fragaki
Kie Itoh
Elodie Villa
Sandra Lacas-Gervais
Manu Jokela
Mari Auranen
Emil Ylikallio
Alessandra Mauri-Crouzet
Henna Tyynismaa
Anna Vihola
Gaelle Augé
Charlotte Cochaud
Hiromi Sesaki
Jean-Ehrland Ricci
Bjarne Udd
Cristofol Vives-Bauza
Véronique Paquis-Flucklinger
spellingShingle Emmanuelle C. Genin
Sylvie Bannwarth
Françoise Lespinasse
Bernardo Ortega-Vila
Konstantina Fragaki
Kie Itoh
Elodie Villa
Sandra Lacas-Gervais
Manu Jokela
Mari Auranen
Emil Ylikallio
Alessandra Mauri-Crouzet
Henna Tyynismaa
Anna Vihola
Gaelle Augé
Charlotte Cochaud
Hiromi Sesaki
Jean-Ehrland Ricci
Bjarne Udd
Cristofol Vives-Bauza
Véronique Paquis-Flucklinger
Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases
Neurobiology of Disease
CHCHD10
SMAJ
FTD-ALS
Mitochondria
TDP-43
author_facet Emmanuelle C. Genin
Sylvie Bannwarth
Françoise Lespinasse
Bernardo Ortega-Vila
Konstantina Fragaki
Kie Itoh
Elodie Villa
Sandra Lacas-Gervais
Manu Jokela
Mari Auranen
Emil Ylikallio
Alessandra Mauri-Crouzet
Henna Tyynismaa
Anna Vihola
Gaelle Augé
Charlotte Cochaud
Hiromi Sesaki
Jean-Ehrland Ricci
Bjarne Udd
Cristofol Vives-Bauza
Véronique Paquis-Flucklinger
author_sort Emmanuelle C. Genin
title Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases
title_short Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases
title_full Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases
title_fullStr Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases
title_full_unstemmed Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases
title_sort loss of micos complex integrity and mitochondrial damage, but not tdp-43 mitochondrial localisation, are likely associated with severity of chchd10-related diseases
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2018-11-01
description Following the involvement of CHCHD10 in FrontoTemporal-Dementia-Amyotrophic Lateral Sclerosis (FTD-ALS) clinical spectrum, a founder mutation (p.Gly66Val) in the same gene was identified in Finnish families with late-onset spinal motor neuronopathy (SMAJ). SMAJ is a slowly progressive form of spinal muscular atrophy with a life expectancy within normal range. In order to understand why the p.Ser59Leu mutation, responsible for severe FTD-ALS, and the p.Gly66Val mutation could lead to different levels of severity, we compared their effects in patient cells. Unlike affected individuals bearing the p.Ser59Leu mutation, patients presenting with SMAJ phenotype have neither mitochondrial myopathy nor mtDNA instability. The expression of CHCHD10S59L mutant allele leads to disassembly of mitochondrial contact site and cristae organizing system (MICOS) with mitochondrial dysfunction and loss of cristae in patient fibroblasts. We also show that G66V fibroblasts do not display the loss of MICOS complex integrity and mitochondrial damage found in S59L cells. However, S59L and G66V fibroblasts show comparable accumulation of phosphorylated mitochondrial TDP-43 suggesting that the severity of phenotype and mitochondrial damage do not depend on mitochondrial TDP-43 localization. The expression of the CHCHD10G66V allele is responsible for mitochondrial network fragmentation and decreased sensitivity towards apoptotic stimuli, but with a less severe effect than that found in cells expressing the CHCHD10S59L allele.Taken together, our data show that cellular phenotypes associated with p.Ser59Leu and p.Gly66Val mutations in CHCHD10 are different; loss of MICOS complex integrity and mitochondrial dysfunction, but not TDP-43 mitochondrial localization, being likely essential to develop a severe motor neuron disease.
topic CHCHD10
SMAJ
FTD-ALS
Mitochondria
TDP-43
url http://www.sciencedirect.com/science/article/pii/S0969996118303486
work_keys_str_mv AT emmanuellecgenin lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT sylviebannwarth lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT francoiselespinasse lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT bernardoortegavila lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT konstantinafragaki lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT kieitoh lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT elodievilla lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT sandralacasgervais lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT manujokela lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT mariauranen lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT emilylikallio lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT alessandramauricrouzet lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT hennatyynismaa lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT annavihola lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT gaelleauge lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT charlottecochaud lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT hiromisesaki lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT jeanehrlandricci lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT bjarneudd lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT cristofolvivesbauza lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
AT veroniquepaquisflucklinger lossofmicoscomplexintegrityandmitochondrialdamagebutnottdp43mitochondriallocalisationarelikelyassociatedwithseverityofchchd10relateddiseases
_version_ 1724207892414857216
spelling doaj-4dd012f21baf4cd2b4f522f52e36c6f32021-03-22T12:47:03ZengElsevierNeurobiology of Disease1095-953X2018-11-01119159171Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseasesEmmanuelle C. Genin0Sylvie Bannwarth1Françoise Lespinasse2Bernardo Ortega-Vila3Konstantina Fragaki4Kie Itoh5Elodie Villa6Sandra Lacas-Gervais7Manu Jokela8Mari Auranen9Emil Ylikallio10Alessandra Mauri-Crouzet11Henna Tyynismaa12Anna Vihola13Gaelle Augé14Charlotte Cochaud15Hiromi Sesaki16Jean-Ehrland Ricci17Bjarne Udd18Cristofol Vives-Bauza19Véronique Paquis-Flucklinger20Université Côte d'Azur, Inserm, CNRS, IRCAN, CHU de Nice, FranceUniversité Côte d'Azur, Inserm, CNRS, IRCAN, CHU de Nice, FranceUniversité Côte d'Azur, Inserm, CNRS, IRCAN, CHU de Nice, FranceResearch Health Institute of Balearic Islands (IdISB)-Research Unit, Son Espases, University Hospital, SpainUniversité Côte d'Azur, Inserm, CNRS, IRCAN, CHU de Nice, FranceDepartment of Cell Biology, Johns Hopkins University Scholl of Medicine, Baltimore, MD, USAUniversité Côte d'Azur, Inserm, C3M, FranceUniversité Côte d'Azur, Centre Commun de Microscopie Appliquée, FranceNeuromuscular Research Center, Tampere University and University Hospital, Tampere, Finland; Department of Clinical Neurosciences, Turku University Hospital, University of Turku, Turku, FinlandClinical Neurosciences, Neurology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, FinlandClinical Neurosciences, Neurology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, FinlandUniversité Côte d'Azur, Inserm, CNRS, IRCAN, CHU de Nice, FranceResearch Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, FinlandFolkhälsan Institute of Genetics, Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki, FinlandUniversité Côte d'Azur, Inserm, CNRS, IRCAN, CHU de Nice, FranceUniversité Côte d'Azur, Inserm, CNRS, IRCAN, CHU de Nice, FranceDepartment of Cell Biology, Johns Hopkins University Scholl of Medicine, Baltimore, MD, USAUniversité Côte d'Azur, Inserm, C3M, FranceNeuromuscular Research Center, Tampere University and University Hospital, Tampere, Finland; Folkhälsan Institute of Genetics, Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki, FinlandResearch Health Institute of Balearic Islands (IdISB)-Research Unit, Son Espases, University Hospital, SpainUniversité Côte d'Azur, Inserm, CNRS, IRCAN, CHU de Nice, France; Corresponding author at: IRCAN UMR CNRS 7284/INSERM U1081/UNS, School of Medicine, 28 av de Valombrose, 06107 Nice cedex 2, France.Following the involvement of CHCHD10 in FrontoTemporal-Dementia-Amyotrophic Lateral Sclerosis (FTD-ALS) clinical spectrum, a founder mutation (p.Gly66Val) in the same gene was identified in Finnish families with late-onset spinal motor neuronopathy (SMAJ). SMAJ is a slowly progressive form of spinal muscular atrophy with a life expectancy within normal range. In order to understand why the p.Ser59Leu mutation, responsible for severe FTD-ALS, and the p.Gly66Val mutation could lead to different levels of severity, we compared their effects in patient cells. Unlike affected individuals bearing the p.Ser59Leu mutation, patients presenting with SMAJ phenotype have neither mitochondrial myopathy nor mtDNA instability. The expression of CHCHD10S59L mutant allele leads to disassembly of mitochondrial contact site and cristae organizing system (MICOS) with mitochondrial dysfunction and loss of cristae in patient fibroblasts. We also show that G66V fibroblasts do not display the loss of MICOS complex integrity and mitochondrial damage found in S59L cells. However, S59L and G66V fibroblasts show comparable accumulation of phosphorylated mitochondrial TDP-43 suggesting that the severity of phenotype and mitochondrial damage do not depend on mitochondrial TDP-43 localization. The expression of the CHCHD10G66V allele is responsible for mitochondrial network fragmentation and decreased sensitivity towards apoptotic stimuli, but with a less severe effect than that found in cells expressing the CHCHD10S59L allele.Taken together, our data show that cellular phenotypes associated with p.Ser59Leu and p.Gly66Val mutations in CHCHD10 are different; loss of MICOS complex integrity and mitochondrial dysfunction, but not TDP-43 mitochondrial localization, being likely essential to develop a severe motor neuron disease.http://www.sciencedirect.com/science/article/pii/S0969996118303486CHCHD10SMAJFTD-ALSMitochondriaTDP-43